NEPHROS INC's ticker is NEPH and the CUSIP is 640671400. A total of 14 filers reported holding NEPHROS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,649 | -4.5% | 36,249 | 0.0% | 0.00% | – |
| Q2 2023 | $56,186 | +44.9% | 36,249 | 0.0% | 0.00% | – |
| Q1 2023 | $38,783 | -7.5% | 36,249 | 0.0% | 0.00% | – |
| Q4 2022 | $41,947 | +27.1% | 36,249 | 0.0% | 0.00% | – |
| Q3 2022 | $33,000 | -40.0% | 36,249 | 0.0% | 0.00% | – |
| Q2 2022 | $55,000 | -65.4% | 36,249 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $159,000 | -25.7% | 36,249 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $214,000 | -32.7% | 36,249 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $318,000 | -13.6% | 36,249 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $368,000 | +52.7% | 36,249 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $241,000 | -22.5% | 36,249 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $311,000 | +18.7% | 36,249 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $262,000 | -13.8% | 36,249 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $304,000 | +40.7% | 36,249 | +5.8% | 0.00% | 0.0% |
| Q1 2020 | $216,000 | -36.7% | 34,249 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $341,000 | +23.6% | 34,249 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $276,000 | – | 34,249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEXFORD CAPITAL LP | 3,395,579 | $21,391,000 | 7.91% |
| BARD ASSOCIATES INC | 207,569 | $2,640,000 | 1.94% |
| Parkman Healthcare Partners LLC | 251,366 | $1,584,000 | 0.73% |
| Cowen Prime Services LLC | 154,800 | $975,000 | 0.60% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 12,957 | $82,000 | 0.07% |
| INGALLS & SNYDER LLC | 133,140 | $839,000 | 0.06% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 39,863 | $251,000 | 0.05% |
| B. Riley Wealth Advisors, Inc. | 14,428 | $91,000 | 0.01% |
| HighTower Advisors, LLC | 43,210 | $273,000 | 0.00% |
| BLAIR WILLIAM & CO/IL | 34,249 | $216,000 | 0.00% |